Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice about a lapse in government funding and the Revision: v3.4.1 notice were removed.SummaryDifference0.4%

- Check38 days agoChange DetectedAdded a site-wide government funding/status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check45 days agoChange DetectedShow glossary has been added; the page now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' metadata, while the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels were removed.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a Locations section with California locations; removed the California Locations header. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.